View Older Stories
-
Increasing unusual option volume: AVTR XIFR DBO BHP VFC SHAZ RSI ACHC VRRM KBWB SKYT CAPR
-
Avantor (AVTR) Tops Q2 EPS by 2c; updates guidance
-
Increasing unusual option volume: AVTR QGEN CAPR RSI GLNG KBR MAT BBD
-
Increasing unusual call option volume: TEL AVTR SHOO SW EH MUU REAL HAS SMWB EQPT SRE
-
Increasing unusual call option volume: AVTR PRMB NNDM EH LASE CE GTM IONS TSLT MUU KORU
-
Bernstein SocGen Group Resumes Avantor Inc. (AVTR) at Market Perform
-
TD Cowen notes short interest shifts in life science tools stocks
-
Increasing unusual option volume: AVTR AMPG OPTU LASE PRGO NASA NNDM CPSH
-
Avantor (AVTR) 9900 contracts of June 10 calls trade
-
Increasing unusual option volume: AVTR OPTU LASE NASA VLN ACLS
-
Wolfe Research Assumes Avantor Inc. (AVTR) at Underperform
-
RBC Capital Assumes Avantor Inc. (AVTR) at Sector Perform
-
Avantor (AVTR) Tops Q1 EPS by 1c
-
Barclays: Life science insiders sold $187M in stock during first quarter
-
Avantor expands microbial testing capacity at St. Louis facility
-
William Blair on Avantor Inc. (AVTR): encouraging to see company make progress toward guide despite CFO departure
-
Increasing unusual option volume: AVTR KBE WEAT DAWN IEP BNO EA
-
Barclays Downgrades Avantor Inc. (AVTR) to Underweight
-
Avantor Inc. (AVTR) PT Lowered to $8 at Jefferies
-
Avantor (AVTR) 6K contracts of February 150 calls trade, share price down 15.8%
-
Avantor Inc. (AVTR) PT Lowered to $11 at BofA Securities
-
Avantor (AVTR) Reports In-Line Q4 EPS
-
Increasing unusual option volume: ZSL AVTR RVMD OPTT TAL URNM
-
Avantor (AVTR) 36K contracts of January 9 puts trade
-
Increasing unusual option volume: AVTR CCCC DAWN VTGN TWO RYAM ULCC ETR
-
Jefferies Downgrades Avantor Inc. (AVTR) to Underperform
-
BofA Securities Downgrades Avantor Inc. (AVTR) to Neutral
-
Nephron Downgrades Avantor Inc. (AVTR) to Sell
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
Increasing unusual option volume: AVTR JBS SLG ELAN
-
Raymond James Downgrades Avantor Inc. (AVTR) to Market Perform
-
Avantor launches sterile sampling platform and PUPSIT assemblies
-
Barclays Downgrades Avantor Inc. (AVTR) to Equalweight
-
JPMorgan Downgrades Avantor Inc. (AVTR) to Neutral
-
Avantor Inc. (AVTR) PT Lowered to $14 at BofA Securities
-
Avantor (AVTR) 53K contracts of November 10 puts trade, share price down 21%
-
Increasing unusual option volume: AVTR GTES PLNT UTHR NOK FI LRN ERIC WU BBWI
-
Avantor (AVTR) Misses Q3 EPS by 1c, Misses on Revenue
-
Avantor (AVTR) call put ratio 1.9 calls to 1 put as share price down 1.5%
-
Avantor partners with p-Chip to develop digital traceability solutions
-
Avantor partners with BlueWhale Bio to improve CAR-T cell manufacturing
-
Avantor names Gregory Summe as board chairman effective January 2026
-
Avantor responds to Engine Capital letter, names new CEO
-
Engine Capital calls for governance changes at Avantor
-
Avantor Inc. (AVTR) PT Lowered to $17 at RBC Capital as 'Revenue Headwinds Persist'
-
Avantor Inc. (AVTR) PT Lowered to $13 at UBS
-
Avantor Inc. (AVTR) PT Lowered to $12 at Stifel
-
Avantor Inc. (AVTR) PT Lowered to $14 at Raymond James
-
Jefferies Downgrades Avantor Inc. (AVTR) to Hold
-
Avantor (AVTR) Misses Q2 EPS by 1c

